Holman, Andrew J <br/><br/>
Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis.  [electronic resource] 

 -  Autonomic neuroscience : basic & clinical  Dec 2008 
 - 58-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1872-7484 
<br/><br/><label>Standard No.: </label>10.1016/j.autneu.2008.05.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Autonomic Nervous System--drug effects<br/>Double-Blind Method<br/>Etanercept<br/>Female<br/>Heart Rate--drug effects<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Tumor Necrosis Factor Inhibitors<br/>Tumor Necrosis Factors--immunology